Ranked United States-based API manufacturers
01 United States
Makes the API
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for cannabidiol, filing since 2018. Its 2021 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Last FDA inspection
2021 · NAI
GMP recognised in
1 markets
02 United States
Makes the API
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for cannabidiol, filing since 2019. Its 2024 FDA inspection closed as VAI.
Last FDA inspection
2024 · VAI
GMP recognised in
Not established
03 United States
Makes the API
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for cannabidiol, filing since 2020.
Last FDA inspection
Not established
GMP recognised in
Not established
04 United States
Makes the API
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for cannabidiol, filing since 2022.
Last FDA inspection
Not established
GMP recognised in
Not established
05 United States
Makes the API
Holds one active US DMF for cannabidiol, filing since 2022.
Last FDA inspection
Not established
GMP recognised in
Not established
06 United States
Makes the API
Credentials confirmed against the regulator files on 25 July 2026
Last FDA inspection
Not established
GMP recognised in
Not established
07 United States
Makes the API
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for cannabidiol, filing since 2018.
Last FDA inspection
Not established
GMP recognised in
Not established
08 United States
Makes the API
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for cannabidiol, filing since 2016. Its 2026 FDA inspection closed as OAI.
Last FDA inspection
2026 · OAI
GMP recognised in
Not established
How this list is built
This page filters the worldwide Cannabidiol manufacturer list to
companies based in United States. The order is set by active filings weighted by regulator,
inspection outcomes and their recency, breadth of GMP recognition, and evidence of real
exports, less any open risk flags.
Read the full method.